{
    "clinical_study": {
        "@rank": "6641", 
        "arm_group": [
            {
                "arm_group_label": "SCu300A IUB", 
                "arm_group_type": "Experimental"
            }, 
            {
                "arm_group_label": "TCu380A", 
                "arm_group_type": "Active Comparator"
            }
        ], 
        "brief_summary": {
            "textblock": "This study aims to evaluate the safety and efficacy of the IUB SCu300A spherical copper  IUD\n      compared to the standard T shaped copper IUD, the TCu380.\n\n      Participants will be followed for one year and quality of life measurements will be measured\n      during this period as well."
        }, 
        "brief_title": "A Study on the Safety and Efficacy of the SCu300A IUB Compared to the TCu380 Copper IUD", 
        "condition": "Reversible Prevention of Pregnancy", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        * Adult females aged 25-42\n\n          -  Free and willing to fully comply with treatment process\n\n          -  Healthy women seeking LARC\n\n          -  Married or in a steady relationship (at least 1 year)\n\n          -  Blood hemoglobin >11.5gr%\n\n          -  Signed informed consent form\n\n          -  If took COCP at least had one cycle after use of OC\n\n        Exclusion Criteria(major)\n\n          -  Use IUB/IUD as an  emergency contraception\n\n          -  A previously placed IUD that has not been removed\n\n          -  Pregnancy or suspicion of pregnancy\n\n          -  Use of other contraception method  (condom for either male or female, oral\n             contraceptives,  diaphragms,  spermicides,  hormonal  patches,  injections  or ring,\n             cervical cap)\n\n          -  History of pelvic inflammatory disease, recent or remote.\n\n          -  Postpartum endometritis or post  abortal endometritis in the past 3 month\n\n          -  Mucopurulent cervicitis\n\n          -  Endometrial thickness more than 12 mm on insertion date\n\n          -  Known anemia\n\n          -  History of previous IUD complications\n\n          -  Dysfunctional uterine bleeding\n\n          -  Undiagnosed uterine bleeding\n\n          -  Malignancy  or  suspected  malignant  disease  of  female  inner  or  outer genitalia\n\n          -  Distortions  of  the  uterine  cavity  by  uterine  fibroids  or  known  anatomical\n             abnormalities\n\n          -  Known  intolerance  or  allergy  to  nitinol  or  copper  and/or  copper  IUDs  -\n             Wilson's disease.\n\n          -  Medication  that  may  interfere  with  the  subject's  ability  to  complete  the\n             protocol\n\n          -  Use of injectable contraception in the previous year\n\n          -  Any  other  significant  disease  or  condition  that  could  interfere  with  the\n             subject's ability to complete the protocol\n\n          -  A history of alcohol or drug abuse\n\n          -  Known infection with human immunodeficiency virus (HIV), Hepatitis B or Hepatitis C\n\n          -  Pregnancy or pregnancy planned during the year\n\n          -  Enrollment (less than 30 days after completing another study) in or planned to be\n             enrolled in another study"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "42 Years", 
            "minimum_age": "25 Years"
        }, 
        "enrollment": {
            "#text": "60", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 23, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02036203", 
            "org_study_id": "AOS-2000-05"
        }, 
        "intervention": [
            {
                "arm_group_label": "SCu300A IUB", 
                "description": "Spherical copper contraceptive", 
                "intervention_name": "SCu300A IUB", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": "TCu380A", 
                "description": "T-shaped copper IUD", 
                "intervention_name": "TCu380A IUD", 
                "intervention_type": "Device"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Contraceptive Agents", 
                "Copper"
            ]
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "January 12, 2014", 
        "location": {
            "contact": {
                "email": "info@oconmed.com"
            }, 
            "facility": {
                "address": {
                    "city": "Netanya", 
                    "country": "Israel"
                }, 
                "name": "Women's Health Center"
            }, 
            "investigator": {
                "last_name": "Yael Barkan, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "Israel"
        }, 
        "number_of_arms": "2", 
        "official_title": "A Prospective, Randomized, Single Blind, Two Arms Controlled Study of the Safety and Efficacy of the SCu300A IUB\u2122 Spherical Copper Intrauterine Ball in Comparison to TCu 380 IUD Intra-uterine Contraceptive Device", 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Israel: Ministry of Health"
        }, 
        "phase": "Phase 2/Phase 3", 
        "primary_completion_date": {
            "#text": "July 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "Number of subjects with partial or complete perforation through the uterine wall", 
                "measure": "Perforation rate", 
                "safety_issue": "Yes", 
                "time_frame": "During device insertion"
            }, 
            {
                "description": "Number of subjects with partially or fully ejected devices", 
                "measure": "Device expulsion", 
                "safety_issue": "Yes", 
                "time_frame": "12 months"
            }, 
            {
                "description": "Number of women who become pregnant during the trial period.", 
                "measure": "Efficacy in preventing pregnancy", 
                "safety_issue": "Yes", 
                "time_frame": "12 months"
            }, 
            {
                "description": "Number of subjects with observed device malposition within the uterine cavity", 
                "measure": "Device malposition", 
                "safety_issue": "Yes", 
                "time_frame": "12 months"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02036203"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "Recording of menstrual pain, cramps and irregular bleeding as reported by subjects.", 
            "measure": "Menorrhagia and dysmenorrhea rates", 
            "safety_issue": "No", 
            "time_frame": "12 months"
        }, 
        "source": "Ocon Medical Ltd.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Ocon Medical Ltd.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "April 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}